— Real-world data and KOL insights highlight MeMed BV’s supportive role in emergency medicine — MeMed, a leader in host-response diagnostics, announced today that several oral presentations at the ...
-- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- In a focused clinical study of 24 women with recurrent BV, once-weekly dosing with ...
MeMed, a leader in host-response diagnostics, announced today that several oral presentations at the upcoming American College of Emergency Physicians (ACEP) Scientific Assembly 2025 will showcase the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback